Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Mycorrhiza|March 12, 2025
The C24-methyl/ethyl sterol ratio is increased by Rhizophagus irregularis colonizationPierre-Emmanuel Courty, Jérôme Fromentin, Lucy Martine, et al.
Cell Host & Microbe|September 15, 2022
The gut microbiome molecular complex in human health and diseasePaul Wilmes, Camille Martin-Gallausiaux, Marek Ostaszewski, et al.
Frontiers in Immunology|January 9, 2019
Butyrate Produced by Commensal Bacteria Down-Regulates Indolamine 2,3-Dioxygenase 1 (IDO-1) Expression via a Dual Mechanism in Human Intestinal Epithelial CellsCamille Martin-Gallausiaux, Pierre Larraufie, Anne Jarry, et al.
ACS Omega|February 4, 2020
Impact of Maleimide Disubstitution on Chemical and Biological Characteristics of HER2 Antibody-Drug ConjugatesOfelia Feuillâtre, Camille Gély, Steve Huvelle, et al.
Cancers|February 15, 2022
Antibody-Drug Conjugates as an Emerging Therapy in OncodermatologyClara Esnault, David Schrama, Roland Houben, et al.
Nature Communications|September 4, 2024
Stable coexistence between an archaeal virus and the dominant methanogen of the human gutDiana P Baquero, Sofia Medvedeva, Camille Martin-Gallausiaux, et al.
Bioconjugate Chemistry|March 20, 2018
Impact of Site-Specific Conjugation of ScFv to Multifunctional Nanomedicines Using Second Generation MaleimideKatel Hervé-Aubert, Emilie Allard-Vannier, Nicolas Joubert, et al.
Mbio|November 11, 2024
Identification of Veillonella parvula and Streptococcus gordonii adhesins mediating co-aggregation and its impact on physiology and mixed biofilm structureLouis Dorison, Nathalie Béchon, Camille Martin-Gallausiaux, et al.
Bioconjugate Chemistry|October 25, 2018
Site-Specific Conjugation of Auristatins onto Engineered scFv Using Second Generation Maleimide to Target HER2-positive Breast Cancer in VitroNicolas Aubrey, Emilie Allard-Vannier, Camille Martin, et al.
Organic & Biomolecular Chemistry|February 24, 2018
Impact of cathepsin B-sensitive triggers and hydrophilic linkers on in vitro efficacy of novel site-specific antibody-drug conjugatesFrancesca Bryden, Camille Martin, Stéphanie Letast, et al.
Pageof 4